Oruka Therapeutics, Inc.
ORKANASDAQNASDAQ Global Market·USD·Closed
$34.23
−$1.03 (2.92%)
$34.23
−$1.03 (2.92%)
Not investment advice.Learn more
52W Range
Near 52-week high
Volume
Market Cap
Small-cap company
P/E Ratio
Div Yield
Strong income stock
ORKA leans slightly negative — a few concerns outweigh the positives.
Continue with finqOS
SEC filings, earnings transcripts, insider trades, institutional ownership, 175+ screening metrics, and an infinite research canvas.
14-day free trial · No credit card required